跳至主要内容

Continuous Flow Chemical Technology

 The continuous flow chemistry technology service platform is one of the important technologies used by Medicilon to support green chemistry. Based on the specific reactions of the innovative drug synthesis process, we can conduct feasibility assessment of continuous reactions, process development and optimization, and continuous improvement of the process to improve the research and development efficiency of the synthesis process and reduce the development cost of innovative drugs.



  • Continuous flow chemistry refers to chemical reactions taking place in a continuously flowing fluid.  Raw materials and reagents are formulated into solutions and pumped into the reaction channels from different containers, where chemical transformations subsequently occur.  Commonly used reactors in continuous flow chemistry are microreactors and medium-sized reactors. Microreactors usually refer to reactors with a three-dimensional structure, whose internal dimensions are less than 1 mm and range from 10 to 100 microns.
    In the context of "double-carbon", "green chemistry" is penetrating into the biopharmaceutical industry.  Only by continuously innovating R&D technology can we open a new door to green chemistry.  In recent years, Medicilon has been closely tracking the latest green chemistry research progress in the industry and is committed to transforming these researches into applicable technologies to promote the green upgrading of pharmaceutical R&D.
    The continuous flow chemistry technology service platform is one of the important technologies used by Medicilon to support green chemistry.  Based on the specific reactions of the innovative drug synthesis process, we can conduct feasibility assessment of continuous reactions, process development and optimization, and continuous improvement of the process to improve the research and development efficiency of the synthesis process and reduce the development cost of innovative drugs.
Advantages of Continuous Flow Chemistry Technology
  • 1) Safe and Stable:1) Safe and Stable:2) Energy Saving and Cost Reduction:Equivalent-sensitive reactions enable good control of substrate dosage; continuous flow equipment has relatively high mass transfer and heat transfer efficiencies, which can reduce solvent usage and achieve energy conservation and consumption reduction by reducing utility engineering specifications or reducing utility usage; continuous flow equipment is generally in a continuous closed form, which reduces various unorganized emissions.3) Efficiently Increase Production:Have obvious enhancement effect on non-homogeneous phase; easily control endothermic and exothermic reactions, the reaction process is close to constant temperature, and the temperature of different multi-stage reactions can be quickly adjusted to the temperature required by the process; parallel amplification of continuous flow reactors can increase production, in addition, extending the operating time of microreactors can also increase product production.
Feasibility Assessment of Continuous Reactions
  • Through literature research and analysis of preliminary experimental results, we have a comprehensive and in-depth understanding of the studied chemical reactions and their reaction mechanisms, and combined with the characteristics of continuous flow equipment to design the continuous flow synthesis process.
    Through literature research and analysis of preliminary experimental results, we have a comprehensive and in-depth understanding of the studied chemical reactions and their reaction mechanisms, and combined with the characteristics of continuous flow equipment to design the continuous flow synthesis process.
    Verify the feasibility-reaction effect and process optimization trend through continuous flow experiments.
    Based on the feasibility analysis results, explore the process optimization content, synthesis route optimization and reaction condition optimization.
    Decision-diagram-for-flow-chemistry.webp
    Image 1. Decision diagram for flow chemistry[1]
Reactive Types for Continuous Flow Applications
  • Low Temperature Reaction (less than -20 degrees)High Temperature Reaction (greater than 150 degrees)Diazomethane ReactionOzonation ReactionPeroxide Participates in Oxidation ReactionsNitrification ReactionPhotochemical ReactionElectrochemical ReactionCatalytic Hydrogenation ReactionPreparation and Application of Organometallic ReagentsReactions such as Azide to Generate High-Energy CompoundsReactions Involving Gases (such as acetylene, ethylene, ammonia, hydrogen, etc.)
Process Development and Optimization
  • On the basis of laboratory synthesis process research, continuous flow synthesis process research was carried out.
    Zones-of-a-standard-two-feed-continuous-flow-setup.webp
    Image 2. Zones of a standard two-feed continuous flow setup[1]
    When studying continuous flow synthesis processes, the experimental plan is usually optimized by adjusting reaction parameters.  These parameters can be divided into input parameters: reaction time, reaction temperature, molar ratio; intrinsic parameters: microreactor volume, stoichiometric ratio, concentration of solution; output parameters: flow rate, microreactor temperature.  In this approach, input parameters are usually selected and intrinsic parameters are used to calculate the output parameters.  The flow rates largely determine the results of continuous flow experiments. The deviation of the flow rate leads to the deviation of the molar ratio of the reaction materials and the reaction time, which leads to the error of the experimental results. It should be highly valued in the research of the continuous flow synthesis process.
    Design of Experiments (DoE) and one-factor rotation experiment (OFAT) are very useful and effective methods in continuous flow reaction optimization.  As needed, select appropriate optimization methods to optimize the process of continuous flow reactions and synthesis routes.
    DOE and OFAT.webp
  • In the future, Medicilon, as a staunch advocate of green chemistry, will actively fulfill its social responsibilities, continue to innovate green R&D technologies, and assist the sustainable development of the biopharmaceutical industry.
    Reference
    [1] M. B. Plutschack, B. Pieber, K.Gilmore, P. H. Seeberger, Chem. Rev.2017,117,11796-11893.
Eqiupment
Continuous Flow Chemical Technology Service Eqiupment.webp

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati